AURA
AURA
NASDAQ · Biotechnology

Aura Biosciences Inc

$6.34
+0.03 (+0.48%)
As of Jun 21, 10:25 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +412.0% upside
Low Target $26.53
Average Target $32.46
High Target $55.40
Current Price $6.34
Current
$6.34
Target
$32.46
$26.53 $32.46 avg $55.40
Scenario Analysis
Bear Case
$26.53
318.5%
Low target
Base Case
$32.46
+412.0%
Avg target
Bull Case
$55.40
+773.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$9.54
-33.5% from high
52-Week Low
$4.73
+34.0% from low
Target vs 52W High
$32.46
+240.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.4%